Therapeutic Antibodies – News and Features

Article
Neutrophils: Neutrophil Function, Origin and Related Conditions
In this article, we consider what neutrophils are, how they are generated, their function in the body and medical conditions related to them.

News
Novel Combination Therapy Shows Promise for Liver Cancer
A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety.

Industry Insight
Tuning the Therapeutic Properties of tRNAs To Treat Rare Diseases
Michelle C. Werner discusses how tRNAs could transform the drug development paradigm from gene-centric to gene-agnostic and accelerate new therapies for 30 million or more patients whose genetically driven disease can be classified under Stop Codon Disease.

News
Fibrin Immunotherapy’s Potential for Treating Traumatic Brain Injury
Traumatic brain injuries come with an amplified risk for developing dementia, but a new therapeutic target and a potential immunotherapy have been identified.

News
Immunotherapy After Kidney Cancer Surgery Improves Overall Survival
For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.

Article
Microbial Monitoring for Biopharma Manufacturing
Contamination is a significant issue for bioprocessing as it results in loss of time, money and effort. This article will explore the pivotal role of microbial monitoring in upholding product safety and quality standards within the biopharmaceutical industry.

News
Designing a Vaccine To Block “Zombie Drug” Xylazine
Scripps Research chemical biologists have developed a vaccine to block the effects of xylazine’s toxicity. The vaccine works by training the immune system to attack the drug, which is described in a new paper published in Chemical Communications.

News
Immunotherapy Clears Amyloid Plaques in Alzheimer’s Mouse Model
Researchers have found a different and promising way to remove the noxious amyloid plaques in Alzheimer's disease: by directly mobilizing immune cells to consume them.

News
Antibody Target Identified Against Crimean Congo Hemorrhagic Fever Virus
CCHFV poses a threat to U.S. military personnel and hospital staff as well as residents of a growing number of countries, says UC Riverside biomedical scientist.

News
Researchers Identify Epstein-Barr Virus’ Weak Points
Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.
Advertisement